Hepatocellular carcinoma (HCC) is the fifth most common cancer and is the second leading
cause of cancer death. Since the diagnosis of HCC is difficult, in many cases patients with …

The lack of an effective treatment against cancer is not only due to its huge heterogeneity,
but also to the fact that we don't have an answer to the question on how cancer originates …

Background CRBP-1, a cytosolic chaperone of vitamin A, is identified in a serious number of
cancers; however, its biological role in hepatocellular carcinoma (HCC) needs to be further …

Hepatocellular carcinoma (HCC) is one of the most common causes of cancer-related death
worldwide. Current treatment options for inoperable HCCs have decreased therapeutic …

Background: Oral squamous cell carcinoma (OSCC) is usually preceded by clinically visible
changes on oral mucosa categorized as oral potentially malignant disorders (OPMD). The …

Ethnopharmacological relevance Luffa cylindrica (L.) M. Roem. has been recognized as
traditional medicine for the treatment of various diseases like inflammatory diseases …

Sorafenib is a multi-kinase blocker and one of the few suggested drug treatments for
aggressive hepatocellular carcinoma (HCC) patients. However, drug resistance to sorafenib …

The treatment for hepatocellular carcinoma (HCC) relies on liver resection, which is,
however, burdened by a high rate of recurrence after surgery, up to 60% at 5 years. No pre …

The search for new therapeutic strategies against cancer has favored the emergence of
rationally designed treatments. These treatments have focused on attacking cell plasticity …

Hepatic stellate cell (HSC) line LX-2 is activated by liver cancer stem-like cells (LCSLCs)
and produces various cytokines that make up most of the hepatocellular carcinoma (HCC) …